Europe Pharmaceutical Packaging Market Size & Trends

Europe Pharmaceutical Packaging Market Size, Segments, Companies, Competitive Analysis, Value Chain & Trade Analysis 2025-2035

The Europe pharmaceutical packaging market, valued at USD 34.00 billion in 2025, is anticipated to reach USD 62.34 billion by 2035, growing at a CAGR of 6.25% over the next decade. The retail pharmacy segment holds the largest share of 55% among end-users. Significant trends include increasing demand for sustainable, tamper-evident packaging, as well as innovations in pre-filled syringes & cartridges, expected to grow at a notable CAGR during 2026-2035.

1. Executive Summary

1.1 Market Snapshot and Key Findings
1.2 Market Size and Forecast Overview (2025-2035)
1.3 Market Volume Analysis and Packaging Consumption Trends
1.4 Pricing Overview Across Packaging Formats and Materials
1.5 Key Demand Drivers and Market Restraints
1.6 Regulatory and Compliance Overview in Europe
1.7 Innovation and Technology Trends in Pharmaceutical Packaging
1.8 Sustainability and Circular Economy Developments
1.9 Competitive Landscape Snapshot
1.10 Strategic Recommendations for Stakeholders
1.11 Analyst Perspective and Future Outlook

2. Introduction and Research Methodology

2.1 Research Objectives
2.2 Market Definition and Scope
2.3 Pharmaceutical Packaging Ecosystem Overview
2.4 Currency, Assumptions, and Forecast Methodology
2.5 Data Collection Methodology
2.6 Primary and Secondary Research Sources
2.7 Market Estimation and Forecasting Model
2.8 Limitations and Validation Framework

3. Market Overview

3.1 Overview of the European Pharmaceutical Industry
3.2 Evolution of Pharmaceutical Packaging in Europe
3.3 Role of Packaging in Drug Safety and Compliance
3.4 Packaging Lifecycle and Product Protection Requirements
3.5 Demand-Supply Scenario Analysis
3.6 Pharmaceutical Packaging Value Chain Overview
3.7 Packaging Material Flow Analysis
3.8 Import–Export Analysis of Pharmaceutical Packaging Materials and Components
3.9 Trade Routes and Regional Manufacturing Hubs
3.10 Industry Ecosystem Mapping

4. Market Size and Forecast Analysis

4.1 Revenue Market Size Analysis (2025–2035)
4.2 Volume Market Analysis by Units and Tons
4.3 Historical Market Analysis (2020–2024)
4.4 Forecast Market Analysis (2025–2035)
4.5 Pricing Trend Analysis by Packaging Type
4.6 Cost Structure Analysis
4.7 Gross Margin and Profitability Assessment
4.8 Demand Forecast by Packaging Segment
4.9 Regional Revenue Contribution Analysis
4.10 Opportunity Assessment by Country

5. Market Dynamics

5.1 Market Drivers
5.1.1 Growth in Generic and Biologic Drug Production
5.1.2 Rising Demand for Sterile and Injectable Packaging
5.1.3 Expansion of E-commerce Pharmacies
5.1.4 Increasing Focus on Patient Safety and Traceability
5.1.5 Growth in Personalized Medicine Packaging

5.2 Market Restraints
5.2.1 Stringent EU Regulatory Requirements
5.2.2 Volatility in Raw Material Prices
5.2.3 Recycling and Sustainability Challenges
5.2.4 Counterfeit Risks and Serialization Costs

5.3 Market Opportunities
5.3.1 Smart and Connected Pharmaceutical Packaging
5.3.2 Sustainable and Recyclable Packaging Innovations
5.3.3 Expansion of Biologics and Cold Chain Packaging
5.3.4 Child-Resistant and Senior-Friendly Packaging
5.3.5 Growth in Contract Packaging Organizations (CPOs)

5.4 Market Challenges
5.4.1 Supply Chain Disruptions
5.4.2 High Compliance Costs
5.4.3 Complex Multilayer Packaging Recycling

5.5 Strategic Insights
5.5.1 White Space Opportunities
5.5.2 Emerging Investment Hotspots
5.5.3 High-Growth Packaging Categories
5.5.4 Strategic Priorities for Manufacturers

6. Regulatory and Policy Landscape

6.1 European Pharmaceutical Packaging Regulatory Framework
6.2 EU GMP Requirements
6.3 Falsified Medicines Directive (FMD)
6.4 Serialization and Track-and-Trace Regulations
6.5 EU Packaging and Packaging Waste Regulation (PPWR)
6.6 Sustainability and Recyclability Standards
6.7 ISO Standards and Quality Certifications
6.8 Country-wise Regulatory Comparison
6.9 Regulatory Impact on Packaging Design and Materials
6.10 Strategic Compliance Insights

7. Technology and Innovation Analysis

7.1 Smart Packaging Technologies
7.2 Anti-counterfeit Technologies
7.3 Digital Printing and Variable Data Printing
7.4 AI and Automation in Packaging Operations
7.5 Advanced Barrier Materials and High-Performance Films
7.6 Blow-Fill-Seal and Aseptic Packaging Innovations
7.7 Sustainable Material Innovations
7.8 RFID and NFC-enabled Pharmaceutical Packaging
7.9 Robotics and Packaging Line Automation
7.10 Technology Adoption Benchmarking
7.11 Innovation Pipeline Analysis

8. Europe Pharmaceutical Packaging Market Analysis by Material Type

8.1 Overview and Market Share by Material Type

8.2 Glass
8.2.1 Market Size and Forecast
8.2.2 Type I Borosilicate Glass Trends
8.2.3 Injectable Packaging Demand
8.2.4 Sustainability and Recycling Trends

8.3 Plastics (HDPE, LDPE, PVC, PET)
8.3.1 Market Dynamics
8.3.2 PET and HDPE Adoption Trends
8.3.3 Lightweighting Innovations
8.3.4 Regulatory Challenges

8.4 Aluminum
8.4.1 Blister Packaging Applications
8.4.2 Foil Barrier Technology Trends

8.5 Paper & Cardboard
8.5.1 Sustainable Secondary Packaging Growth
8.5.2 Carton Packaging Trends

8.6 Multi-Layer Laminates
8.6.1 High-Barrier Packaging Demand
8.6.2 Recyclability Challenges

8.7 Strategic Insights by Material Type

9. Europe Pharmaceutical Packaging Market Analysis by Packaging Type

9.1 Overview and Market Share by Packaging Type

9.2 Bottles & Jars
9.3 Blister Packs
9.4 Vials & Ampoules
9.5 Pouches & Sachets
9.6 Pre-Filled Syringes & Cartridges
9.7 Tubes
9.8 Others (Cans, Drums, Specialized Containers)

9.9 Market Attractiveness Analysis by Packaging Type
9.10 Innovation Trends by Packaging Format
9.11 Strategic Insights by Packaging Type

10. Europe Pharmaceutical Packaging Market Analysis by Dosage Form

10.1 Overview and Market Share by Dosage Form

10.2 Oral Solid (Tablets, Capsules)
10.3 Oral Liquid (Syrups, Suspensions)
10.4 Injectable (Vials, Prefilled Syringes)
10.5 Topical (Creams, Gels, Ointments)
10.6 Inhalation & Nasal
10.7 Others (Suppositories, Powders)

10.8 Dosage-form Packaging Compatibility Analysis
10.9 Strategic Insights by Dosage Form

11. Europe Pharmaceutical Packaging Market Analysis by End-User

11.1 Hospitals & Clinics
11.2 Retail Pharmacies
11.3 E-commerce / Online Pharmacies
11.4 Contract Manufacturing Organizations (CMOs)
11.5 Market Size and Forecast by End-User
11.6 Packaging Demand Analysis by Healthcare Channel
11.7 Strategic Insights by End-User

12. Europe Pharmaceutical Packaging Market Analysis by Distribution Channel

12.1 Direct Sales
12.2 Distributors & Wholesalers
12.3 Online Platforms
12.4 Market Share Analysis by Distribution Channel
12.5 Supply Chain and Distribution Efficiency Assessment
12.6 Strategic Insights by Distribution Channel

13. Regional Market Analysis

13.1 Europe Market Overview

13.2 Germany
13.2.1 Market Size and Forecast
13.2.2 Pharmaceutical Manufacturing Landscape
13.2.3 Packaging Innovation Trends
13.2.4 Competitive Environment

13.3 France
13.4 United Kingdom
13.5 Italy
13.6 Spain
13.7 Rest of Europe

13.8 Regional Comparative Benchmarking
13.9 Regional Trade and Supply Chain Analysis
13.10 Strategic Regional Insights

14. Supply Chain and Value Chain Analysis

14.1 Raw Material Suppliers
14.2 Packaging Manufacturers
14.3 Pharmaceutical Companies
14.4 Contract Packaging Organizations
14.5 Distribution and Logistics Providers
14.6 Recycling and Waste Management Ecosystem
14.7 Supply Chain Risk Assessment
14.8 Value Addition Analysis Across the Chain
14.9 Strategic Insights on Supply Chain Optimization

15. Competitive Landscape Analysis

15.1 Market Structure and Competition Overview
15.2 Market Share Analysis of Key Players
15.3 Tier-wise Competitive Benchmarking
15.4 Revenue and Capacity Comparison
15.5 Product Portfolio Benchmarking
15.6 Geographic Presence Analysis
15.7 Strategic Developments
15.7.1 Mergers and Acquisitions
15.7.2 Partnerships and Collaborations
15.7.3 Capacity Expansion
15.7.4 Product Launches
15.7.5 Sustainability Initiatives

15.8 Porter’s Five Forces Analysis
15.9 Competitive Positioning Matrix
15.10 Strategic Insights on Competitive Intensity

16. Company Profiles

16.1 AptarGroup, Inc.
16.2 Berry Global, Inc.
16.3 WestRock Company
16.4 Gerresheimer AG
16.5 Schott AG
16.6 Stevanato Group S.p.A.
16.7 Becton Dickinson & Co.
16.8 SGD Pharma
16.9 West Pharmaceutical Services, Inc.
16.10 Amcor plc
16.11 Nipro Corporation
16.12 Lonza Group AG
16.13 CCL Industries
16.14 Catalent, Inc.
16.15 Stölzle Glass Group
16.16 Rommelag Kunststoff-Maschinen Vertriebsgesellschaft mbH
16.17 Essentra plc
16.18 Huhtamaki Oyj
16.19 Clariant AG
16.20 Bormioli Pharma S.p.A.

(Each profile includes)
• Company Overview
• Business Segments
• Product Portfolio
• Financial Overview
• Packaging Capabilities
• Regional Presence
• Recent Developments
• Strategic Outlook

17. Sustainability and Circular Economy Analysis

17.1 Sustainable Packaging Trends in Europe
17.2 Recyclability and Material Recovery Analysis
17.3 Carbon Footprint Assessment
17.4 ESG Benchmarking of Key Companies
17.5 Circular Packaging Initiatives
17.6 Bio-based and Recyclable Pharmaceutical Packaging
17.7 Sustainability Roadmap and Future Targets
17.8 Strategic Sustainability Insights

18. Investment and Funding Analysis

18.1 Investment Trends in Pharmaceutical Packaging
18.2 Venture Capital and Private Equity Activity
18.3 Capacity Expansion Investments
18.4 M&A Landscape
18.5 Government Grants and Incentives
18.6 Startup and Innovation Ecosystem
18.7 Strategic Investment Opportunities

19. Strategic Market Analysis

19.1 PESTLE Analysis
19.2 Porter’s Five Forces Analysis
19.3 Market Attractiveness Matrix
19.4 Pricing Strategy Analysis
19.5 Growth Opportunity Mapping
19.6 Emerging Business Models
19.7 Blue Ocean Opportunity Assessment
19.8 Scenario Analysis (Optimistic, Base, Pessimistic)
19.9 Strategic Recommendations for Stakeholders

20. Future Outlook and Forecast

20.1 Future Market Size Projections
20.2 Technology Evolution Outlook
20.3 Sustainable Packaging Adoption Forecast
20.4 Smart Packaging Penetration Forecast
20.5 Regional Growth Outlook
20.6 Long-Term Industry Transformation Trends
20.7 Analyst Recommendations and Conclusion

Meet the Team

Vidyesh Swar

Vidyesh Swar

Principal Research Analyst

Vidyesh Swar is a Senior Research Analyst at Towards Packaging, bringing over 4 years of dedicated expertise in market intelligence and strategic analysis across the dynamic world of packaging technologies and solutions.

Learn more about Vidyesh Swar
Aditi Shivarkar

Aditi Shivarkar

Reviewed By

Aditi Shivarkar, with 14+ years in packaging market research, specializes in food, beverage, and eco-friendly packaging. She ensures accurate, actionable insights, driving Towards Packaging Analytics & Consulting 's excellence in industry trends and sustainability.

Learn more about Aditi Shivarkar

FAQ's

Answer : The Europe pharmaceutical packaging market is valued at USD 34 billion in 2025 and is projected to reach USD 58.67 billion by 2034, growing at a CAGR of 6.25%.

Answer : Growth is driven by stringent drug safety regulations, rising pharmaceutical production.

Answer : Plastics hold the largest share at around 45% in 2024, thanks to their lightweight, cost-effectiveness.